Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PROPYLTHIOURACIL Cause Treatment failure? 12 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Treatment failure have been filed in association with PROPYLTHIOURACIL (Propylthiouracil). This represents 1.3% of all adverse event reports for PROPYLTHIOURACIL.

12
Reports of Treatment failure with PROPYLTHIOURACIL
1.3%
of all PROPYLTHIOURACIL reports
0
Deaths
4
Hospitalizations

How Dangerous Is Treatment failure From PROPYLTHIOURACIL?

Of the 12 reports, 4 (33.3%) required hospitalization, and 4 (33.3%) were considered life-threatening.

Is Treatment failure Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PROPYLTHIOURACIL. However, 12 reports have been filed with the FAERS database.

What Other Side Effects Does PROPYLTHIOURACIL Cause?

Drug ineffective (121) Foetal exposure during pregnancy (110) Anti-neutrophil cytoplasmic antibody positive vasculitis (81) Exposure during pregnancy (75) Hyperthyroidism (58) Off label use (54) Maternal exposure during pregnancy (50) Agranulocytosis (42) Vasculitis (41) Premature baby (38)

What Other Drugs Cause Treatment failure?

METHOTREXATE (14,672) ETANERCEPT (11,893) ADALIMUMAB (9,990) ABATACEPT (9,301) RITUXIMAB (9,217) TOCILIZUMAB (9,097) HYDROXYCHLOROQUINE (8,786) LEFLUNOMIDE (8,686) INFLIXIMAB (8,535) SULFASALAZINE (7,423)

Which PROPYLTHIOURACIL Alternatives Have Lower Treatment failure Risk?

PROPYLTHIOURACIL vs PROTAMINE PROPYLTHIOURACIL vs PROTHIPENDYL PROPYLTHIOURACIL vs PROTIONAMIDE PROPYLTHIOURACIL vs PROTONIX PROPYLTHIOURACIL vs PROTOPIC

Related Pages

PROPYLTHIOURACIL Full Profile All Treatment failure Reports All Drugs Causing Treatment failure PROPYLTHIOURACIL Demographics